Please wait while the transcript is being prepared...
0:00
Hello everyone. Today,
we're going to talk about
the scope of pharmaceutical
companies at the
corporate level.
This is Radi Haloub speaking.
I'm an associate professor
and program leader for
Biotech and
Pharmaceutical Management
at UCL Global Business
School for Health.
0:17
The aim of the session today is
to answer some of
the questions like:
can portfolio management
create a group value:
to whom and why?
Then I will introduce you
to the frames for analyzing
the portfolio using
McKinsey directional policy
matrix and parenting matrix.
Then I will introduce
you to the role of
parent company and
synergistic approach
within the
pharmaceutical industry.
You always need to
think about how
pharmaceutical industries
created their own identities
in the market, and how they
are well established in
certain types of diseases.
Some of the companies
are established
in certain diseases.
Some of them would
like to diversify
in different business units.
So we're going to
talk today about
how companies invest in these,
what is their role
as a parent company
to provide a
synergistic approach,
and who we're going to benefit
and why are they going
to benefit from this?
1:14
It's always a case where
the pharmaceutical
companies would
create a value for
their business units.
How these views can impact
the portfolio management?
Which strategic business units
to invest in and which to sell?
For example,
pharmaceutical companies,
they might have the
cardiovascular line,
they might have the
cancer therapy,
they might have gene therapy
and these are three
business units.
These three business
units can be
research-driven or
can be market-driven.
From that perspective, creating
group value from the
company is the ability of
the company to enrich
business units
in different dimensions
to become successful.
So, which one to invest
in and which one to sell?
Then, the parenting is how
should the parent add value?
The strength of
the business unit
in the cardiovascular line,
and it offers loads of
products in the market
would need more investment
into their business units.
But when you look
at the parenting
the cancer therapy, they
need the parenting to
add value to their
product portfolio.
So, creating a value group is
quite important in
portfolio analysis.
There are different styles
